Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
NIH.gov Diabetes, Obesity, and Metabolism
They are not FDA-approved as finished drugs
In Phase 3 SURMOUNT trials, Retatrutide achieved unprecedented 24.2% mean weight loss at the 12mg dose over 48 weeks, with 91% of participants achieving 15% body weight reduction
The practice is now in-network with Anthem Blue Cross Blue Shield, Harvard Pilgrim, UnitedHealthcare, Aetna, Cigna, Ambetter, and Mass General Brigham Health Plans, making insurance-covered access to prescription weight loss care more accessible than ever for patients throughout Rockingham County, Windham, Derry, and beyond
US$ 29.86
US$ 20.54
US$ 28.92
US$ 28.99
US$ 23.30
US$ 24.50
US$ 21.24
US$ 23.96
US$ 24.65
US$ 23.50
US$ 23.48
